I. Supplemental Methods

Cohort descriptions
For the description of the CHARGE consortium and participating cohorts we refer to the CHARGE design paper(1). In short, the AGES -Reykjavik Study represents a sample from the population-based Reykjavik Study, originally comprising 31,795 individuals.
Between 2002 and 2006 the AGES -Reykjavik Study 5 ,764 survivors of the original cohort were re-examined (2) . The ARIC study is a population-based prospective cohort study, sponsored by the National Heart, Lung, and Blood Institute, and included 15,792 individuals aged 45 to 64 years at baseline from 4 US communities(3). CHS is a National Heart, Lung, and Blood Institute sponsored population-based cohort study in adults over 65 years of age conducted at 4 field centers. Originally CHS 5,201 predominantly white individuals were enrolled in 1989-1990(4) . The FHS started in 1948 with the recruitment of an original cohort of 5,209 men and women aged 28 to 62 years of age (5) . In 1971, children and spouses of children of the original cohort were enrolled (6) . The third generation cohort enrollment started in 2002 and comprises 4,095 children of offspring cohort participants.(7) The RS is a prospective population-based cohort study comprising 7,983 subjects aged 55 years or older (RS-I) (8) . In 2000-2001, an additional 3,011 individuals aged 55 years or older (RS-II) were recruited (9) .
In addition to cohorts in the CHARGE consortium, additional cohorts participated and are discussed below. EUROSPAN consists of five isolated population cohorts. For the current effort we used ECG measurements that were available in three of the participating studies, namely ERF, MICROS and ORCADES. The studied populations originate from Rucphen, (The Netherlands), South Tyrol (Italy) and the Orkney Islands (Scotland, UK), respectively. The Erasmus Rucphen Study (ERF) is derived from a recent genetic isolate in the southwest Netherlands. This population was founded in the middle of the 18th century by approximately 150 individuals and was isolated until the last few decades. Twenty couples living in the region in the 19th century were chosen. These couples parented a minimum of 6 children, each of whom was baptized between 1880 and 1900 in the community church. All living descendants of these pairs (as well as their spouses), ascertained on the basis of municipal and baptismal records, were traced and invited to participate. The MICROS study is part of the genomic health care program 'GenNova' and was carried out in three villages of the Val Venosta on the populations of Stelvio, Vallelunga and Martello. This study was an extensive survey carried out in South Tyrol (Italy) in the period [2001] [2002] [2003] . An extensive description of the study is available elsewhere (10) . Briefly, study participants were volunteers from three isolated villages located in the Italian Alps, bordering with Austria and Switzerland. Due to geographical, historical and political reasons, the entire region experienced prolonged isolation from surrounding populations. The Orkney Complex Disease Study (ORCADES) is an ongoing family-based, cross-sectional study in the isolated Scottish archipelago of Orkney. Genetic diversity in this population is decreased compared to Mainland Scotland, consistent with the high levels of endogamy historically. Data for participants aged 18-88 years, from a subgroup of ten islands, were used for this analysis. The is an ongoing 8-year longitudinal cohort study to examine (predictors of) the long-term course of depression and anxiety disorders. The rationales, methods and recruitment strategy have been described elsewhere (12) . Subjects were recruited in various settings (community, general practices, mental health organizations) and include subjects with and without depression and anxiety disorders.The SardiNIA study is a population based study, that recruited and phenotyped 6,148 individuals, male and female, ages 14-102 years, from a cluster of four towns in the Lanusei Valley of Sardinia (13) . For the GWA scans a total of 4,305 related individuals were examined (14) . Genotyped individuals had four Sardinian grandparents and were selected without regard to their phenotypes. The Study of Health in Pomerania (SHIP) is a longitudinal population-based cohort study in West Pomerania, a region in the northeast of Germany with a total population of 212,157 inhabitants (15) . A twostage cluster sampling method adopted from the WHO MONICA Project Augsburg, Germany yielded 12 five-year age strata for both genders, each including 292 individuals. For the baseline cohort, a sample of 6,267 eligible subjects aged 20 to 79 years was drawn from population registries where all German citizens are registered. The final study population compromised 4,310 subjects (response proportions 69%). The Twins UK Registry comprises unselected, mostly female volunteers ascertained from the general population through national media campaigns in the UK (16) . Means and ranges of quantitative phenotypes in Twins UK were similar to an age-matched singleton sample from the general population (17) .
Zygosity was determined by standardized questionnaire and confirmed by DNA fingerprinting. Written informed consent was obtained from all participants before they entered the studies, which were approved by the local research ethics committee.
Phenotype measurement
In ARIC, RR interval was measured automatically from 12-lead ECGs performed at baseline. The study ECGs were recorded using MAC PC ECG machines (Marquette Electronics, Milwaukee, Wisconsin) in all four clinical centers. All ECGs were visually inspected for technical errors and inadequate quality. ECGs were initially processed in a central laboratory at the EPICORE Center (University of Alberta, Edmonton, Alberta, Canada) and during later phases of the study at the EPICARE Center (Wake Forest University, Winston-Salem, North Carolina). Initial ECG processing was done by the In CHS, electrocardiograms were recorded using MAC PC ECG machines (Marquette Electronics, Milwaukee, Wisconsin) in all clinical centers. ECGs were initially processed in a central laboratory at the EPICORE Center (University of Alberta, Edmonton, Alberta, Canada) and during later phases of the study, at the EPICARE Center (Wake Forest University, Winston-Salem, North Carolina). All ECGs were visually inspected for technical errors and inadequate quality. RR interval was calculated from heart rate using the baseline ECG for eligible subjects. Initial ECG processing was done by the Dalhousie ECG program, and processing was later repeated with the 2001 version of the GE Marquette 12 SL program (GE Marquette, Milwaukee, Wisconsin).
In FHS, paper electrocardiograms were scanned and digital caliper measurements were made using proprietary software (eResearchTechnology, generations 1 and 2) or using In KORA F3 and S4 12-lead resting electrocardiograms were recorded with digital recording systems (KORA F3: Mortara Portrait, Mortara Inc., Milwaukee, USA; KORA S4:
Hörmann Bioset 9000, Hörmann Medizinelektronik, Germany). The Mortara Portrait determines RR interval by the proprietary XL-ECG algorithm which has not been published but has shown to be in good accordance with other published electrocardiogram measurement algorithms (18) ; RR interval in KORA S4 (Hörmann Bioset) was determined using the Hannover EKG analysis software (HES-Version 3. by computerized analysis of all leads and all cycles of a 10 second interval as described earlier. (19, 20) In the Hannover algorithm RR intervals are taken as the intervals between the reference points detected in adjacent QRS complexes. The mean RR interval was computed, after exclusion of RR intervals that immediately precede and follow any premature ventricular complex. Only ECGs classified as "appropriate technical quality" according to visual inspection were used. The ECG examinations in both studies were performed according to a standard protocol, after ten minutes resting in supine position.
In MICROS 12-lead resting ECGs were recorded using a digital recording system (Mortara Portrait, Mortara, Milwaukee, WI, USA). The Mortara Portrait determines RR interval by the proprietary XL-ECG algorithm. In brief, computerized analysis of an averaged cycle computed from all leads and all cycles of the 10 second recording after exclusion of ectopic beats was performed. RR intervals were determined as the intervals between the reference points detected in adjacent QRS complexes. The median RR interval was computed, after exclusion of RR intervals that immediately precede and follow any premature ventricular complex.
In NESDA, all respondents received an average physiological recording of 100 minutes, performed with the 'Vrije Universiteit Ambulatory Monitoring System" (21) . The VU-AMS is a light-weight ambulatory device that records the electrocardiogram (ECG) from three electrodes in lead II configuration and changes in thorax impedance (dZ) from four electrodes placed at chest and back of the subjects. From the R-waves in the ECG signal the inter beat intervals (IBI) were computed online and the IBI time series was visually checked for ectopic beats or missed R-waves offline. For the GWA mean heart rate was computed across valid IBIs across ten minutes of quiet supine rest at the start of the recording period.
In ORCADES digital 10 second ECGs were taken after 10 minutes supine rest, using a PC link with RR interval calculated using CardioView software (NUMED cardiac diagnostics, Sheffield, UK).
In the RS-I and RS-II, electrocardiograms were recorded on ACTA electrocardiographs (ESAOTE, Florence, Italy) and digital measurements of the RR intervals were made using the Modular ECG Analysis System (MEANS) (22) In SardiNIA the RR interval was calculated from heart rate that was measured from the electrocardiogram (measured on Cardiette 600 machines) during physical examination.
In TwinsUK, ECG data were available on 3,043 individuals before exlcusions. Two thousand seven hundred twenty six had automated measurements of the RR interval by the Cardiofax ECG-9020K (Nihon Kohden UK Ltd., Middlesex, UK) and 317 were scored manually using a high-resolution digitizing board (GTCO CalComp Peripherals, USA). The dataset for analyses consequently included 2,727 individuals, of which 1980 were DZ twins (i.e. 990 pairs) and 747 singletons. These singletons included 474 MZ twins of which the mean RR interval of both twins was used to optimize information.
Genotyping and imputation
A summary of the following information is given in eTable 1.
In AGES, blood was drawn at entry into the AGES Reykjavik study (2002) (2003) (2004) (2005) (2006) .
Using the Illumina 370CNV BeadChip array, 3,219 participants were genotyped. Samples were excluded from the dataset based on sample failure, genotype mismatch with reference panel and genotypic-phenotypic sex mismatch. Standard Illumina genotyping protocols were followed. Prior to genotype imputation SNPs were excluded using filters for call rate (<97%), Hardy-Weinberg disequilibirum (P<1x10 In ARIC, Affymetrix 6.0 array genotypes were obtained in 8,861 self-identified whites: 734 individuals were excluded for the following reasons: 1) discordant with previous genotype data, 2) genotypic sex did not match phenotypic sex, 3) suspected first degree relative of an included individual based on genome-wide genotype data, 4) genetic outlier (as assessed by average Identity by State (IBS) using PLINK and >8 standard deviations along any of first 10 principal components in EIGENSTRAT after 5 iterations. To be included for imputation, SNPs were required to have minor allele frequency ≥0.01, call rate ≥95% and HWE p >1x10 -5 , resulting in 602,642 autosomal SNPs. Imputation was performed using MACH v1.0.16(23) with reference to HapMap CEU human genome release 21a build 35.
In CHS, genomic DNA was extracted from blood samples drawn on all participants at their baseline examination in 1989-90. Genotyping was performed at the General Clinical Research Center's Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV BeadChip system in 2007-08. Genotypes were called using the Illumina BeadStudio software. Filtering of both individuals and SNPs was performed to ensure robustness for genetic analysis. Samples were excluded from analysis for sex mismatch, discordance with prior genotyping, or call rate <95%. SNPs were excluded from analysis for HWE P<10 -5 . SNPs with call rates <95% were manually reclustered using the Illumina software, or zeroed accordingly. A final SNP set of 306,655 SNPs was identified. Imputation was performed using BIMBAM (i) v0.99 with reference to HapMap CEU using release 22 human genome build 36, using one round of imputations and the default expectation-maximization warm-ups and runs. SNPs were excluded for variance on the allele dosage ≤0.01.
In the EUROSPAN cohorts genotyping was performed using the Illumina 300
HumanHap Bead Chip. ERF included an additional 200 subjects previously genotyped on Affymetrix 250k. In ERF and MICROS only SNPs with a call rate>98%, MAF 1% and HWE
P>10
-6 were used for imputation using MACH v1.0.16 (23) Array Set, we took advantage of the relatedness among individuals to impute missing genotypes as described elsewhere (14, 26) . Our inference approach allowed us to account for uncertainty in genotype assignment, estimating, instead of the most likely genotype, an expected genotype score, representing the expected number of copies of a reference allele (a fractional number between 0 and 2).
In SHIP, samples were genotyped using the Affymetrix Human SNP Array 6.0.
Hybridization of genomic DNA was done in accordance with the manufacturer's standard recommendations. The genetic data analysis workflow was created using InforSense software.
Genetic data were stored using the Caché (InterSystems) database. Genotypes were determined using the Birdseed2 clustering algorithm. For quality control purposes, several control samples where added. On the chip level, only subjects with a genotyping rate on QC probesets (QC callrate) of at least 86% were included. The overall genotyping efficiency of the GWA was 98.6 %. Imputation of genotypes in SHIP was performed with IMPUTE v0.5.0 based on HapMap (release 22, build 36).
Samples from the TwinsUK cohort were genotyped with the Infinium assay (Illumina, San Diego, USA) using four different SNP arrays, the Hap300 Duo, Hap300, Hap550 and Hap610 (27) . SNP calling was performed using the Illuminus software (28 Genotype-phenotype association method In AGES and ARIC, RR interval residuals were tested for association with ProbABEL, which uses dosage values (0-2, continuous) as a predictor in a linear regression framework (31) . In CHS, RR interval was linearly regressed on individual allele dosage (0-2), adjusting for covariates of age, sex, clinic, and BMI. Analyses were performed using R software. In FHS, linear mixed effects regression model accounting for within pedigree correlation was applied for association testing of the RR interval residuals with imputed allele dosage under an additive genetic model using the linear mixed effects model of the kinship package in R to account for relatedness. In KORA F3, KORA S4, RS-I and RS-II, RR interval residuals were tested for association with genotypes using MACH2QTL, which uses dosage value as a predictor in a linear regression framework (23) .
All three EUROSPAN cohorts performed the association analysis using ProbABEL (31) . In ERF, a mixed-model approach was implemented to account for the family structure.
Adjustments were made for sex, age and body mass index in an additive genetic model.
Standard errors of effect estimates and association p-values were adjusted using genomic control (32) to correct the distribution of p-values that could be skewed in inbred populations.
In SardiNIA, genotype scores were included in the family-based association test for evaluating the additive effect of each marker, as described elsewhere (26) and implemented in Merlin (33) . Due to computational constraints, we divided large pedigrees into sub-units with "bit-complexity" of 19 or less (typically, 20-25 individuals) before all the analyses. In SHIP and NESDA, RR intervals were tested for association using SNPTEST v1.1.5 with a linear regression model based on allele dosage and adjustment for sex, age and BMI. In TwinsUk, RR interval was adjusted for age, sex, and body mass index using regression models. In addition a covariate for the method of measurement (automatically vs. manually scored) of the ECG was incorporated. RR interval residuals were used for further analyses. Association between RR interval residuals and autosomal SNPs was tested in SNPTEST v1.1.4. As the TwinsUK cohort data consisted partly of dizygotic twins, the variances of the regression coefficients were corrected for the sibship relations using the Huber-White method for robust variance estimation in R(34,35).
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Supplemental Figure 1 . Quantile -Quantile plots of observed/expected -log 10 (P) per cohort and meta-analysis.
X-axis: P-value thresholds below which all independent signals meeting this threshold were included in the regression model to estimate the explained variance in the RS-II sample.
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Supplemental Figure 2 . Graphical presentation of the multiple variant modeling approach estimating explained variance in the RS-II sample.
Left Y-axis: explained variance in the RS-II sample for any given score at the different P-value thresholds.
Right Y-axis: number of independent SNPs included in the model for a given P-value threshold.
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